Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Summary: Background: The population impact of pneumococcal conjugate vaccines (PCVs) depends on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV (PCV13) in 2011, we examined its impact on vaccine and non-vaccine serotype invasive pneumococcal disease among v...

Full description

Bibliographic Details
Main Authors: Naor Bar-Zeev, PhD, Todd D Swarthout, MSc, Dean B Everett, ProfPhD, Maaike Alaerts, PhD, Jacquline Msefula, BSc, Comfort Brown, Dipl, Sithembile Bilima, BSc, Jane Mallewa, MD, Carina King, PhD, Anne von Gottberg, ProfPhD, Jennifer R Verani, MD, Cynthia G Whitney, MD, Charles Mwansambo, FRCPCH, Stephen B Gordon, ProfPhD, Nigel A Cunliffe, ProfPhD, Neil French, ProfPhD, Robert S Heyderman, ProfPhD
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X21001650

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X21001650

Similar Items